Arkolith/Insider Trading/EVMN/Form 4

Pivotal bioVenture Partners Fund I G.P., L.P.

Director, 10% OwnerEvommune, Inc. (EVMN) · full profile →Form 4 · filed Nov 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
3 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2025Conversion(C)1.6M——1.6M
Nov 7, 2025Conversion(C)1.4M——1.4M
Nov 7, 2025Conversion(C)295K——295K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 7, 2025Conversion(C)2.1M——0
Nov 7, 2025Conversion(C)1.9M——0
Nov 7, 2025Conversion(C)7.2M——0
Nov 7, 2025Conversion(C)2.6M——0
Nov 7, 2025Conversion(C)3.6M——0
Nov 7, 2025Conversion(C)7.1M——0
Nov 7, 2025Conversion(C)2.5M——0
Nov 7, 2025Conversion(C)314K——0
Nov 7, 2025Conversion(C)314K——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001012975-25-000730) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML